Search results
Lupin loses appeal in EU court, will have to pay €40 mn fine in Perindopril case - CNBC TV18
CNBC TV18· 1 day agoThe European Court of Justice has upheld the European Commission’s decision to impose a fine of 40...
Lupin, Eugia recall products from US market: USFDA
The Economic Times· 6 days agoNew Delhi: Drugmaker Lupin and a unit of Aurobindo Pharma are recalling products from the American market due to manufacturing issues, according to the...
Lupin shares gain 1.77% as Sensex rises
The Economic Times· 1 day agoA total of 34,891 shares changed hands on the counter till 10:35AM (IST)
Stock market update: Nifty Pharma index advances 1.11%
The Economic Times· 1 day agoThe Nifty Pharma index closed 1.11 per cent up at 19731.55.
Stock market update: Nifty Pharma index advances 1.37% in an upbeat market
The Economic Times· 1 day agoThe Nifty Pharma index was trading 1.37 per cent up at 19782.05.
Pharma industry body mulling policy framework to guide cos on cybercrime
Business Standard India· 2 days agoThere is a need for pharmaceutical companies to have a policy framework within the Indian...
PLI scheme for obesity, diabetes drugs likely by 2026: Report
Business Today· 24 hours agoIndian pharma companies such as Dr. Reddy's Laboratories, Lupin, Zydus Cadila, and Sun Pharma are...
Drugmaker Servier loses EU court fight over pay-for-delay deals - ET HealthWorld | Pharma
The Economic Times· 2 days agoBlood Pressure Medicine: "The Court dismisses the appeals of Lupin, Niche Generics, Unichem...
India plans incentives for diabetes, obesity drug makers in 2026, government official says - ET...
The Economic Times· 1 day agoBengaluru: India is planning to offer incentives to promote local manufacturing of GLP-1 drugs used...
For the next big leap, leading Indian CDMOs mull a new policy advocacy group - ET HealthWorld | ...
The Economic Times· 5 days ago(contract development and manufacturers organization) are close to forming a group with the aim for...